CEAPRO INC.
TSX VENTURE : CZO

CEAPRO INC.

May 31, 2007 08:00 ET

Ceapro Inc. appoints VP Business Development

EDMONTON, May 31 - Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or the
"Corporation") today announced the appointment of Ian W. Cottrell, Ph.D as
Vice President Business Development.

Ian Cottrell is an experienced executive with extensive business acumen
and technological expertise, having worked with both established and
entrepreneurial profit centers spanning North America, Europe and the Pacific
Rim. He has experience in establishing and aligning business, marketing and
technology strategies, and a record of developing revenues and cost savings
from new product and process development. His expertise is based on over 30
years' experience in specialty chemical, biotechnology and consumer products.

Most recently, Ian Cottrell was responsible for the development of
specialty pet products for the Animal Health and Grooming categories at The
Hartz Mountain Corporation. Dr Cottrell received his Ph.D. in organic
chemistry from the University of Edinburgh, Scotland.

"Ceapro has devoted time and significant brain power to developing its
core competencies. Of late, a number of consumer products have come of this
investment and it is time to have an executive devoted to business
development. Dr Cottrell's addition to the Ceapro team gives our company depth
of experience and expertise in that realm," said Dr. Mark Redmond, the
Corporation's President and CEO. "His specific knowledge as well as his
significant market experience will help bring Ceapro to the next level of
commercialization success."

About Ceapro Inc.

Ceapro Inc is a Canadian growth-stage biotechnology company. Ceapro's
core technology is the extraction of functional, active ingredients from
plants and other renewable resources. We add further value to our extracts by
manufacturing medical and therapeutic products, and by supporting the use of
our extracts in products for human and animal health. We have also introduced
health and wellness services employing our CeaProve® diagnostic technology.
Our most recent initiative is the creation of Ceapro BioEnergy Inc. (CBE), a
wholly-owned subsidiary to utilize Ceapro's proprietary technology for the
production of ethanol and value-added products. Ceapro shares trade on the
Canadian TSX Venture Exchange under the symbol CZO. To learn more about
Ceapro, visit our website at www.ceapro.com.


The TSX has neither approved nor disapproved of the information contained herein -

This release may contain forward-looking statements. Various factors
could cause actual results to differ materially from those projected in
forward-looking statements. Although the Company believes that the
forward-looking statements contained herein are reasonable, it can give no
assurance that the Company's expectations are correct. All forward-looking
statements are expressly qualified in their entirety by this cautionary
statement.

Contact Information

  • Dr. Mark Redmond, President and CEO, Ceapro
    Inc., Telephone (Edmonton): (780) 421-4555; Nicole Blanchard, B.Sc., B.Comm.,
    Managing Partner, Sun International Communications, Telephone (Montreal):
    (450) 627-6600